학술논문

Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Document Type
article
Source
Frontiers in Immunology, Vol 15 (2024)
Subject
autoimmune disease (AID)
immune checkpoint inhibitors (ICI)
autoimmune liver diseases (AILD)
immune related adverse effects (irAEs)
PD-1/PD-L1 immune checkpoint inhibitors
autoimmune hepatitis (AIH)
Immunologic diseases. Allergy
RC581-607
Language
English
ISSN
1664-3224